Ultrasound measures of muscle morphology in people with multiple sclerosis are associated with muscle performance and functional mobility

Mañago, Mark M.; Seamon, Bryant A.; Boncella, Katie L.; Wallin, Mitchell T.; Maloni, Heidi; Hoover, Brian; Blackman, Marc R.; Harris-Love, Michael O.

doi:10.1016/j.msard.2023.104759

Cited by 4 publications

(1 citation statement)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, unlike traditional static imaging, real-time ultrasound allows for the direct observation of muscle at rest and in motion, giving immediate feedback on the muscle quality [44] and performance [45]. The possibility to perform a dynamic evaluation is important not only in the differential diagnosis with other potential causes of muscle weakness but also to evaluate the impact of sarcopenia on a patient's daily life [46,47]. All the abovementioned advantages make MUS a useful option for assessing and monitoring sarcopenia over time in healthcare settings.…”

Section: Advantages Of Ultrasound In the Diagnosis Of Sarcopeniamentioning

confidence: 99%

Ultrasound Evaluation of Sarcopenia in Patients with Hepatocellular Carcinoma: A Faster and Easier Way to Detect Patients at Risk

Esposto,

Borriello,

Galasso

et al. 2024

Diagnostics

View full text Add to dashboard Cite

The condition of sarcopenia, defined as a progressive loss of musculoskeletal mass and muscular strength, is very common in patients with hepatocellular carcinoma (HCC) and presents a remarkable association with its prognosis. Thus, the early identification of sarcopenic patients represents one of the potential new approaches in the global assessment of HCC, and there is increasing interest regarding the potential therapeutic implications of this condition. The gold standard for the quantification of muscle mass is magnetic resonance imaging (MRI) or computed tomography (CT), but these techniques are not always feasible because of the high-cost equipment needed. A new possibility in sarcopenia identification could be muscle ultrasound examination. The measurement of specific parameters such as the muscle thickness, muscular fascicles length or pennation angle has shown a good correlation with CT or MRI values and a good diagnostic accuracy in the detection of sarcopenia. Recently, these results were also confirmed specifically in patients with chronic liver disease. This review summarizes the role of imaging for the diagnosis of sarcopenia in patients with HCC, focusing on the advantages and disadvantages of the diagnostic techniques currently validated for this aim and the future perspectives for the identification of this condition.

show abstract